AcipHex.com—E-mail a Friend

Print this page |

E-mail a friend

Send to a friend

If you would like to send this page to a friend or to yourself as a reminder, simply fill in the e-mail address of the recipient, your name and e-mail address, and click "Send e-mail."

Your friend will receive an e-mail with a direct link to this information, along with a notification that you requested it.

We do not maintain or capture any names during this process.
See our Privacy Policy.

Please complete the following information. All fields are required.

Friend’s name (recipient):

Friend’s e-mail address (recipient):

Your name:

Your e-mail address:

In adults (≥18 years of age), one ACIPHEX 20 mg tablet daily is used for the treatment of persistent, frequent (2 or more days a week) heartburn and other symptoms associated with acid reflux disease. ACIPHEX is also used for the short-term (4 to 8 weeks) treatment in the healing and symptom relief of damaging (erosive) acid reflux disease (gastroesophageal reflux disease) and to maintain healing of damage (erosion) and relief of heartburn symptoms that happen with acid reflux disease. ACIPHEX has not been studied for treatment lasting longer than 12 months (1 year).

In adolescents (≥12 years of age), one ACIPHEX 20 mg tablet daily is used for the treatment of persistent, frequent (2 or more days a week) heartburn and other symptoms associated with acid reflux disease.

IMPORTANT SAFETY INFORMATION
ACIPHEX has a well-established safety profile.

In adolescents, the most common side effects with ACIPHEX include headache, diarrhea, nausea, vomiting, and abdominal pain.

In adults, the most common side effects with ACIPHEX include pain, sore throat, gas, infection, and constipation.

Symptom relief does not rule out other serious stomach conditions.

Before taking ACIPHEX, tell your doctor if you are taking atazanavir, digoxin, iron salts, ketoconazole, or warfarin.

To learn more, talk to your doctor and see the Full Product Information.

ACIPHEX is a registered trademark of Eisai Company, Ltd., Tokyo, Japan.
©2009 Eisai Inc. and PriCara^®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
This site originates in the United States.

This information is intended for use by our customers, patients, healthcare professionals and interested parties in the United States only. Eisai Inc. and PriCara^®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., recognize that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here is not appropriate for use outside the United States.
This site contains information about products that may have different product labeling in different countries.
This site is published by Eisai Inc. and PriCara^®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., which are solely responsible for its contents.

This site was last modified on: July 13, 2009 at 5:30:00 EST